FDA allows generic forms of Endo Health's Opana ER painkiller

(Reuters) - The U.S. Food and Drug Administration on Friday denied Endo Health Solutions' petition to block generic forms of its widely abused prescription pain drug Opana ER, a surprise decision by an agency that has recently come down hard on pain drugs to prevent their abuse.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news